XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 13, 2024, Mark P. Brosius, the Companys Senior Vice President and Chief Manufacturing and Supply Chain Officer, adopted a Rule 10b5-1 trading plan. Mr. Brosius’s trading plan provides for the potential sale of up to 7,972 shares of the Company’s common stock, including the potential exercise and sale of up to 4,221 shares of the Company’s common stock subject to stock options, until June 13, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Gary S. Guthart [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On April 30, 2024, Gary S. Guthart, Ph.D., the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Dr. Guthart’s trading plan provides for (i) potential exercises of vested stock options to purchase up to 50,400 shares of the Company’s common stock, (ii) potential sales of shares of the Company’s common stock received upon such exercises to cover exercise costs, estimated tax withholding amounts, and customary brokerage fees as well as potential additional sales of such shares, (iii) the potential donation of 12,500 shares of the Company’s common stock from a trust in which Dr. Guthart is a trustee, and (iv) potential sales of up to 14,880 shares of the Company’s common stock held by trusts in which the beneficiaries are children of Dr. Guthart, until April 30, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Gary S. Guthart, Ph.D.
Title Chief Executive Officer and a member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 30, 2024
Arrangement Duration 365 days
Amal M. Johnson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 2, 2024, Amal M. Johnson, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Ms. Johnson’s trading plan provides for the potential exercise and sale of up to 7,578 shares of the Company’s common stock subject to an option until May 2, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Amal M. Johnson
Title member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 2, 2024
Arrangement Duration 365 days
Aggregate Available 7,578
Jamie E. Samath [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 6, 2024, Jamie E. Samath, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 trading plan. Mr. Samath’s trading plan provides for the potential sale of up to 32,200 shares of the Company’s common stock, including the potential exercise and sale of up to 26,703 shares of the Company’s common stock subject to stock options, until May 6, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Jamie E. Samath
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 6, 2024
Arrangement Duration 365 days
Henry L. Charlton [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On May 24, 2024, Henry L. Charlton, the Company’s Chief Commercial and Marketing Officer, adopted a Rule 10b5-1 trading plan. Mr. Charlton’s trading plan provides for the potential sale of up to 40,243 shares of the Company’s common stock, including the potential exercise and sale of up to 19,758 shares of the Company’s common stock subject to stock options, until May 26, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Henry L. Charlton
Title Chief Commercial and Marketing Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 24, 2024
Arrangement Duration 367 days
Gary H. Loeb [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 10, 2024, Gary H. Loeb, the Company’s General Counsel and Chief Compliance Officer, adopted a Rule 10b5-1 trading plan. Mr. Loeb’s trading plan provides for the potential sale of up to 300 shares of the Company’s common stock until June 10, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Gary H. Loeb
Title General Counsel and Chief Compliance Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 10, 2024
Arrangement Duration 365 days
Aggregate Available 300
Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Name Mark P. Brosius
Title Senior Vice President and Chief Manufacturing and Supply Chain Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 13, 2024
Arrangement Duration 365 days
Amy L. Ladd [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 14, 2024, Amy L. Ladd, M.D., a member of the Companys Board of Directors, adopted a Rule 10b5-1 trading plan. Dr. Ladd’s trading plan provides for the potential sale of up to 600 shares of the Company’s common stock, until July 25, 2025. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Amy L. Ladd, M.D.
Title member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 14, 2024
Arrangement Duration 406 days
Aggregate Available 600
Gary S. Guthart Trading Arrangement, Common Stock [Member] | Gary S. Guthart [Member]  
Trading Arrangements, by Individual  
Aggregate Available 50,400
Gary S. Guthart Trading Arrangement, Trust, Common Stock [Member] | Gary S. Guthart [Member]  
Trading Arrangements, by Individual  
Aggregate Available 12,500
Gary S. Guthart Trading Arrangement, Beneficiary, Common Stock [Member] | Gary S. Guthart [Member]  
Trading Arrangements, by Individual  
Aggregate Available 14,880
Jamie E. Samath Trading Arrangement, Common Stock [Member] | Jamie E. Samath [Member]  
Trading Arrangements, by Individual  
Aggregate Available 32,200
Jamie E. Samath Trading Arrangement, Stock Options [Member] | Jamie E. Samath [Member]  
Trading Arrangements, by Individual  
Aggregate Available 26,703
Henry L. Charlton Trading Arrangement, Common Stock [Member] | Henry L. Charlton [Member]  
Trading Arrangements, by Individual  
Aggregate Available 40,243
Henry L. Charlton Trading Arrangement, Stock Options [Member] | Henry L. Charlton [Member]  
Trading Arrangements, by Individual  
Aggregate Available 19,758
Mark P. Brosius Trading Arrangement, Common Stock [Member] | Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Aggregate Available 7,972
Mark P. Brosius Trading Arrangement, Stock Options [Member] | Mark P. Brosius [Member]  
Trading Arrangements, by Individual  
Aggregate Available 4,221